Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C BURNETT

Showing results (41-50 of 921) with videos related to

Pageof 93
Sort By:
International Journal of Molecular Sciences|March 28, 2018
Particulate Guanylyl Cyclase A/cGMP Signaling Pathway in the Kidney: Physiologic and Therapeutic IndicationsYang Chen, John C Burnett
Frontiers in Physiology|February 28, 2022
Natriuretic Peptides and Blood Pressure Homeostasis: Implications for MANP, a Novel Guanylyl Cyclase a Receptor Activator for HypertensionValentina Cannone, John C Burnett
Circulation|May 20, 2009
Soluble guanylate cyclase: not a dull enzymeGuido Boerrigter, John C Burnett
Circulation Journal : Official Journal of the Japanese Circulation Society|May 30, 2017
Atrial Natriuretic Peptide　- Old But New Therapeutic in Cardiovascular DiseasesTomoko Ichiki, John C Burnett
European Heart Journal|June 3, 2017
BLAST-AHF: insights into biased AT1 ligands and heart failure. Beginning of the end or end of the beginning?Shinobu Sugihara, John C Burnett
Circulation. Heart Failure|July 3, 2020
Natriuretic Peptides, Inflammation, and Sounding the AlarmVijay Ramakrishnan, John C Burnett
Journal of the American College of Cardiology|August 20, 2011
Natriuretic peptides renal protective after all?Guido Boerrigter, John C Burnett
Expert Opinion on Investigational Drugs|June 4, 2004
Recent advances in natriuretic peptides in congestive heart failureGuido Boerrigter, John C Burnett
Clinica Chimica Acta; International Journal of Clinical Chemistry|December 3, 2014
Pathophysiology and the cardiorenal connection in heart failure. Circulating hormones: biomarkers or mediatorsAlessia Buglioni, John C Burnett
Clinical Chemistry|January 8, 2017
Biochemistry, Therapeutics, and Biomarker Implications of Neprilysin in Cardiorenal DiseaseYang Chen, John C Burnett
Pageof 93

Showing results (41-50 of 921) with videos related to

Sort By:
Pageof 93
International Journal of Molecular Sciences|March 28, 2018
Particulate Guanylyl Cyclase A/cGMP Signaling Pathway in the Kidney: Physiologic and Therapeutic IndicationsYang Chen, John C Burnett
Frontiers in Physiology|February 28, 2022
Natriuretic Peptides and Blood Pressure Homeostasis: Implications for MANP, a Novel Guanylyl Cyclase a Receptor Activator for HypertensionValentina Cannone, John C Burnett
Circulation|May 20, 2009
Soluble guanylate cyclase: not a dull enzymeGuido Boerrigter, John C Burnett
Circulation Journal : Official Journal of the Japanese Circulation Society|May 30, 2017
Atrial Natriuretic Peptide　- Old But New Therapeutic in Cardiovascular DiseasesTomoko Ichiki, John C Burnett
European Heart Journal|June 3, 2017
BLAST-AHF: insights into biased AT1 ligands and heart failure. Beginning of the end or end of the beginning?Shinobu Sugihara, John C Burnett
Circulation. Heart Failure|July 3, 2020
Natriuretic Peptides, Inflammation, and Sounding the AlarmVijay Ramakrishnan, John C Burnett
Journal of the American College of Cardiology|August 20, 2011
Natriuretic peptides renal protective after all?Guido Boerrigter, John C Burnett
Expert Opinion on Investigational Drugs|June 4, 2004
Recent advances in natriuretic peptides in congestive heart failureGuido Boerrigter, John C Burnett
Clinica Chimica Acta; International Journal of Clinical Chemistry|December 3, 2014
Pathophysiology and the cardiorenal connection in heart failure. Circulating hormones: biomarkers or mediatorsAlessia Buglioni, John C Burnett
Clinical Chemistry|January 8, 2017
Biochemistry, Therapeutics, and Biomarker Implications of Neprilysin in Cardiorenal DiseaseYang Chen, John C Burnett
Pageof 93